Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Metastatic Castration-resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Early research (Phase 1)Study completedNCT03805594
What this trial is testing

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+4 more
University of California, San Francisco 43
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)Study completedNCT00140400
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 50
Testing effectiveness (Phase 2)Ended earlyNCT03752099
What this trial is testing

To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Veru Inc. 80
Large-scale testing (Phase 3)Study completedNCT01057810
What this trial is testing

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 837
Testing effectiveness (Phase 2)Looking for participantsNCT04104776
What this trial is testing

Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more
Novartis Pharmaceuticals 300
Early research (Phase 1)Looking for participantsNCT07641049
What this trial is testing

Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerAdvanced Prostate AdenocarcinomaPSCA-positive Prostate Cancer+1 more
Beijing Biotech 36
Early research (Phase 1)Ended earlyNCT00511576
What this trial is testing

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Who this might be right for
Breast CancerLung CancerPulmonary Cancer+5 more
Mirati Therapeutics Inc. 54
Post-approval studies (Phase 4)Active Not RecruitingNCT03016741
What this trial is testing

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+2 more
Northwestern University 100
Testing effectiveness (Phase 2)Ended earlyNCT00906243
What this trial is testing

RNActive®-Derived Therapeutic Vaccine

Who this might be right for
Hormone Refractory Prostate Cancer
University of Florida 6
Testing effectiveness (Phase 2)Looking for participantsNCT05888532
What this trial is testing

64Cu-GRIP B in Patients With Advanced Malignancies

Who this might be right for
Prostate CancerRenal CancerUrethral Cancer+3 more
Rahul Aggarwal 91
Large-scale testing (Phase 3)Active Not RecruitingNCT06551324
What this trial is testing

Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer 600
Not applicableUnknownNCT03177551
What this trial is testing

Predictive Nomogram of CRPC

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Tianjin Medical University Second Hospital 300
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Early research (Phase 1)Looking for participantsNCT07533708
What this trial is testing

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

Who this might be right for
mCRPC or Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Next Page